Article Details

Jim Mellon's Juvenescence takes a chance on tiny upstart run by former Pfizer exec

Retrieved on: 2019-03-26 23:00:00

Tags for this article:

Click the tags to see associated articles and topics

Jim Mellon's Juvenescence takes a chance on tiny upstart run by former Pfizer exec. View article details on hiswai:

Excerpt

<div>... with AI groups, such as Alex Zhavoronkov's AI shop at <b>Insilico Medicine</b> — while gaining controlling interests in firms including AgeX and LyGenesis.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up